View Cart  

FDA Details Time Clock Strategies for PMAs, 510(k)s in Draft Guidance

A A
The FDA last week released updated guidance describing how it intends to comply with submission review timelines set during user fee negotiations earlier this year.

To View This Article:

Login

Subscribe To Devices & Diagnostics Letter

Buy This Article Now

Add this article to your cart for $25.00